Executive Medical Director, Medical Strategy (Hepatologist)
Core
Senior hepatologist leading medical strategy and scientific evidence generation for MASH therapeutics.
Role type
Executive Medical Director, Medical Strategy (Hepatologist)
Builds
Strategic medical direction and evidence generation for resmetirom (Rezdiffra) and future assets.
Domain
Biopharmaceuticals / Hepatology / Metabolic Dysfunction–Associated Steatohepatitis (MASH)
Deliverable
production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work
Required skills
Hepatology clinical expertise, MASH disease knowledge, pharmaceutical industry strategy, regulatory compliance, HEOR collaboration, publication strategy, advisory board management, cross-functional leadership
Preferred skills
None stated
Technologies
None stated
Responsibilities
Shape global medical strategy for MASH assets, provide scientific guidance to commercial and market access teams, lead evidence generation for Phase 4 and post-approval studies, manage investigator-initiated study governance, serve on medical product and regulatory committees, mentor field medical teams
Seniority
Executive, strategic leadership & cross-functional integration
